was read the article
array:21 [ "pii" => "X2013251409004572" "issn" => "20132514" "doi" => "10.3265/Nefrologia.2009.29.3.5327.en.full" "estado" => "S300" "fechaPublicacion" => "2009-06-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2009;29:193-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4024 "formatos" => array:3 [ "EPUB" => 242 "HTML" => 3213 "PDF" => 569 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699509004575" "issn" => "02116995" "doi" => "10.3265/Nefrologia.2009.29.3.5327.en.full" "estado" => "S300" "fechaPublicacion" => "2009-06-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2009;29:193-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 8958 "formatos" => array:3 [ "EPUB" => 255 "HTML" => 8056 "PDF" => 647 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Biobancos: una nueva herramienta para la investigación clínica" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "193" "paginaFinal" => "195" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Biobanks: a new tool for clinical research" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "169108_mostrarfile3.jpg" "Alto" => 426 "Ancho" => 1750 "Tamanyo" => 153515 ] ] "descripcion" => array:1 [ "es" => "Dificultades asociadas con la puesta en marcha de los biobancos" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F Liaño, AM Torres" "autores" => array:2 [ 0 => array:2 [ "Iniciales" => "F" "apellidos" => "Liaño" ] 1 => array:2 [ "Iniciales" => "AM" "apellidos" => "Torres" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251409004572" "doi" => "10.3265/Nefrologia.2009.29.3.5327.en.full" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004572?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509004575?idApp=UINPBA000064" "url" => "/02116995/0000002900000003/v0_201502091409/X0211699509004575/v0_201502091409/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251409004556" "issn" => "20132514" "doi" => "10.3265/Nefrologia.2009.29.3.5290.en.full" "estado" => "S300" "fechaPublicacion" => "2009-06-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2009;29:196-202" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4383 "formatos" => array:3 [ "EPUB" => 236 "HTML" => 3648 "PDF" => 499 ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "FGF23 in chronic kidney disease and kidney post-transplant patients" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "196" "paginaFinal" => "202" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "El FGF23 en la insuficiencia renal crónica y el post-transplante renal" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "17018078_f1_p198.jpg" "Alto" => 337 "Ancho" => 398 "Tamanyo" => 16798 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Armando Luis Negri" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Armando Luis" "apellidos" => "Negri" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699509004559" "doi" => "10.3265/Nefrologia.2009.29.3.5290.en.full" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509004559?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004556?idApp=UINPBA000064" "url" => "/20132514/0000002900000003/v0_201502091629/X2013251409004556/v0_201502091629/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251409004580" "issn" => "20132514" "doi" => "10.3265/Nefrologia.2009.29.3.5326.en.full" "estado" => "S300" "fechaPublicacion" => "2009-06-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2009;29:185-92" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4287 "formatos" => array:3 [ "EPUB" => 239 "HTML" => 3523 "PDF" => 525 ] ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Strategies for renal health: a project of the Spanish Society of Nephrology" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "185" "paginaFinal" => "192" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "ESTRATEGIAS EN SALUD RENAL: UN PROYECTO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGIA." ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => " Grupo de Acción Estratégica de la S.E.N., A Martínez Castelao, ALM de Francisco, JL Górriz, R Alcázar, L. Orte" "autores" => array:6 [ 0 => array:1 [ "apellidos" => "Grupo de Acción Estratégica de la S.E.N." ] 1 => array:2 [ "Iniciales" => "A" "apellidos" => "Martínez Castelao" ] 2 => array:2 [ "nombre" => "ALM" "apellidos" => "de Francisco" ] 3 => array:2 [ "Iniciales" => "JL" "apellidos" => "Górriz" ] 4 => array:2 [ "Iniciales" => "R" "apellidos" => "Alcázar" ] 5 => array:2 [ "Iniciales" => "L." "apellidos" => "Orte" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699509004583" "doi" => "10.3265/Nefrologia.2009.29.3.5326.en.full" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509004583?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004580?idApp=UINPBA000064" "url" => "/20132514/0000002900000003/v0_201502091629/X2013251409004580/v0_201502091629/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Biobanks: a new tool for clinical research" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "193" "paginaFinal" => "195" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "F Liaño, AM Torres" "autores" => array:2 [ 0 => array:3 [ "Iniciales" => "F" "apellidos" => "Liaño" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "Iniciales" => "AM" "apellidos" => "Torres" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Nefrología y Departamento de Medicina, 1Biobanco del Hospital Universitario Ramón y Cajal-CIFRA, Madrid, Madrid, España, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Servicio de Nefrología, 1Biobanco del Hospital Universitario Ramón y Cajal-CIFRA, Madrid, Madrid, España, " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Biobancos: una nueva herramienta para la investigación clínica" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "16918078_t1_p195.jpg" "Alto" => 225 "Ancho" => 826 "Tamanyo" => 44167 ] ] "descripcion" => array:1 [ "en" => "Difficulties involved in starting up biobanks" ] ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara">Biobank is an establishment containing biological samples that are associated with clinical information. These samples are collected, processed, stored and managed according to quality criteria in order to make them available to serve society in a non-profit way with the aim of promoting biomedical investigation.</p><p class="elsevierStylePara">As we infer from that definition, biobanks are not the active agent for a single centre’s research; rather, they are complementary tools to facilitate the research of others. Biobanks have come to be in the last five years; their origin lies in the enormous growth of scientific production in biomedicine, the need to coordinate basic and clinical studies by fostering cooperative models, and the possibility of increasing the efficiency of informed consent so that the same biological material may serve for different studies. Naturally, all of this must be done according to criteria ensuring the quality and suitability of the stored samples, and the ethical and legal requirements that guarantee citizens’ rights. Although these factors were already being taken into account be researchers, they were not precisely regulated. The combination of all of the above aspects led to the development of biobanks being considered a top-priority strategic need by both the EEC and, at the Spanish national level, the Carlos III Health Institute.</p><p class="elsevierStylePara">Biobanks are intended to produce wealth through creating a mass of human <span class="elsevierStyleItalic">biological capital</span> intended to foster biomedical research and the promotion of health. Samples must have an <span class="elsevierStyleItalic">overall quality</span> that is not only associated with their collection and storage conditions, but also to their traceability and the precision and reliability of the clinical data associated with those samples.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Present and future of biobanks</span></p><p class="elsevierStylePara">At this time, few biobanks are present in Spain. Due to strategic initiatives by health authorities in this country, an important development is foreseen in the near future. The development of a biobank passes through the following phases: defining its purpose, predicting necessities, obtaining funding, installing infrastructure and preparing techniques, preparing documentation, implementing a management system, and beginning operations. In the medium term, biobanks will begin to function as a network, to maximise their potential on both the national and European levels.</p><p class="elsevierStylePara">Biobanks could be intended to manage the biological material that would be necessary to develop a large project, which would become increasingly associated with a high degree of specialisation (National DNA Bank). They could also attend to the needs of an institution - a hospital, for example - or they could study a disease, as is the case of the Spanish HIV BioBank. These purposes would not be exclusive, although in the future we would expect a tendency towards a certain degree of specialisation.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Bases for guaranteeing the effectiveness of biobanks</span></p><p class="elsevierStylePara">As mentioned previously, biobanks are a very effective tool at the service of the scientific community. When storing samples on a large scale, complex technical procedures must necessarily be used for sample collection, transport, identification, traceability maintenance, storage at the proper temperature, and for computerised data processing, etc. The bases that will guarantee the effectiveness of biobanks will comprise:</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Standardisation of procedures</span>: the use of homogeneous, well-defined protocols for sample collection, processing, conservation and storage will guarantee sample quality. Well-defined standard notation of associated data will also create quality clinical information. This will reflect the sample’s importance as biological capital, since a sample with no associated information lacks value. On the other hand, the fact that the collection and storage of samples and associated clinical data will not be scattered among different groups, centres, collections, etc. will mean that all samples will share the same conditions and will be able to be compared with each other in different studies.</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Guaranteed sample traceability</span>, by drawing on proper methodology for sample coding and identification, which will guarantee its traceability at all times.</p><p class="elsevierStylePara">- A <span class="elsevierStyleItalic">dynamic</span> and <span class="elsevierStyleItalic">effective management</span> by means of computer applications that allow us to list all of the processes to which samples and associated data have been submitted.</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">The implementation of a quality management system</span> to make the organisation function effectively, improving biobank customer satisfaction.</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Employment of qualified personnel</span> who will be exclusively dedicated to the operation of the biobank.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Bases for managing biobanks in Spain</span></p><p class="elsevierStylePara">The entire process that takes place from collecting the samples up to their use by researchers must be in accordance with applicable legislation, which for biobanks is principally composed of:</p><p class="elsevierStylePara">- Spanish Law 14/2007 of 3 July regarding biomedical research,<span class="elsevierStyleSup">1</span> which contemplates its origins and regulates its organisation, functioning and records. At present, there is no developmental legislation to clarify it, meaning that we must wait to know what conditions will be necessary for authorisation and for havinga national registry. By law, biobanks must guarantee the quality, safety and traceability of the biological data and samples that they house. Likewise, they must guarantee protection of the rights of subjects who have donated biological material and who may be affected by the research.</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Organic Law 15/1999 of 13 December regarding the Protection of Personal Data</span>.<span class="elsevierStyleSup">2</span> This law must be applied to samples from identifiable subjects and to samples for which identification could be re-associated or decoded, which are considered to be personal health-related data. It requires guaranteeing confidentiality and the proper useof samples in the exclusive field of the approved research study. The law does not apply to anonymous or irreversibly dissociated samples.</p><p class="elsevierStylePara">Biobanks may be owned publicly or privately, but for all cases they must be non-profit organisations. Their organisational scheme must contain a scientific director and a file manager, and in addition, they must be attached to two external committees: a scientific committee and an ethics committee.</p><p class="elsevierStylePara">Legal considerations for using biological samples are different for biobanks and sample collections. In both cases, however, the informed consent of the source subject is necessary in order to obtain the samples. Given biobanks’ mission of public service, consent is granted in more wide-ranging terms. This means it is not necessary to give details about the specific project in which the sample is to be used, as would be the case for collections; also, there must be a clause regarding ceding the sample to third parties, which is also impossible for normal data collecting without obtaining further consent.</p><p class="elsevierStylePara">In this way, samples can be kept indefinitely in a biobank and be at the scientific community’s disposal for future investigations that are not planned atthe moment the sample is taken. The nature of the sample is respected in any case.</p><p class="elsevierStylePara">Samples can be provided at no cost for use in research projects that have been approved by both the scientific and ethics sides.</p><p class="elsevierStylePara">Only the minimum necessary quantity will be ceded. Samples and associated data that are transferred will be kept anonymous or dissociated. In the cession agreement, the researcher will commit to not use the sample for any purpose other than that for which the sample was requested. Likewise, he/she may not cede the sample to third parties.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Who benefits from biobank development?</span></p><p class="elsevierStylePara">We expect that the benefits provided by biobanks will affect various segments of the population, including the following:</p><p class="elsevierStylePara">- Researchers:</p><p class="elsevierStylePara">- Sample quality and organisation criteria allow them to carry out epidemiological studies under proper conditions.<br></br>- Biobanks provide them with legal and ethical assessment and regulate the exchange of biological samples for investigation using standard procedures and transparent workings.<br></br>- Biobanks act as an instrument for cooperative investigation that is multi-centre, interdisciplinary and multi-sectorial.<br></br>- Biobanks contribute to gaining new financing and patents for the Health System.</p><p class="elsevierStylePara">- Patients:</p><p class="elsevierStylePara">- By using biological samples, researchers can develop biomarkers and target treatments that may lead to advances in prediction, early diagnosis and disease treatment methods.</p><p class="elsevierStylePara">- Society in general:</p><p class="elsevierStylePara">- Biobanks may serve to develop diagnostic tools for preventing diseases.<br></br>- They may identify risk factors if studies are carried out relating lifestyles or environmental factors with diseases.<br></br>- The creation of <span class="elsevierStyleItalic">biological capital</span> will foster the creation of social wealth by acting as a factor promoting the development of the pharmaceutical industry.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Other considerations related to biobanks</span></p><p class="elsevierStylePara">Despite the positive aspects that biobanks can contribute, summarised above, their start-up is not free from difficulties, some of which are shown in table 1.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Biobanks and Nephrology</span></p><p class="elsevierStylePara">Our speciality is not unaware of the need to have these tools at our disposal, and in the future they will be completely necessary if we wish to deepen our study of the diseases that concern us. In addition, the possibility of real-time access to samples stored in biobanks will further increase nephrologists’ capacity for research. Given that the SEN (Spanish Society of Nephrology) has been a participative scientific society throughout its history, we are certain that the development of biobanks will lead to better cooperation among us, increasing our research potential, and therefore our contribution to improving care for kidney disease patients. Although we are still in a develop ment phase,<span class="elsevierStyleSup">3</span> we are placing the Ramon y Cajal UH-CIFRA biobank at the disposal of Spanish nephrologists wishing to use it for their projects.</p><p class="elsevierStylePara"><a href="grande/16918078_t1_p195.jpg" class="elsevierStyleCrossRefs"><img src="16918078_t1_p195.jpg" alt="Difficulties involved in starting up biobanks"></img></a></p><p class="elsevierStylePara">Table 1. Difficulties involved in starting up biobanks</p>" "pdfFichero" => "P-E-S-A169-EN.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "16918078_t1_p195.jpg" "Alto" => 225 "Ancho" => 826 "Tamanyo" => 44167 ] ] "descripcion" => array:1 [ "en" => "Difficulties involved in starting up biobanks" ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "LEY 14/2007, de 3 de julio, de Investigación biomédica. BOE 4 julio 2007, núm. 159: pág. 28826" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Ley Orgánica 15/1999, de 13 de diciembre, de Protección de Datos de Carácter Personal. BOE 14 diciembre 1999, núm. 298: pág. 43088" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "AM. Torres, MT. Tenorio, A. Candela, JM. Del Rey, A. Tejedor, L. Boscá, F. Liaño. Creación del Biobanco de Fracaso Renal Agudo de la Comunidad de Madrid: una herramienta para la nefrología española. Nefrología 2008; 28 (supl. 4): 30. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18457558" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000002900000003/v0_201502091629/X2013251409004572/v0_201502091629/en/main.assets" "Apartado" => array:4 [ "identificador" => "35429" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorials" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002900000003/v0_201502091629/X2013251409004572/v0_201502091629/en/P-E-S-A169-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004572?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 8 | 11 | 19 |
2024 October | 55 | 44 | 99 |
2024 September | 50 | 31 | 81 |
2024 August | 60 | 56 | 116 |
2024 July | 56 | 30 | 86 |
2024 June | 58 | 28 | 86 |
2024 May | 47 | 28 | 75 |
2024 April | 65 | 20 | 85 |
2024 March | 34 | 19 | 53 |
2024 February | 63 | 36 | 99 |
2024 January | 40 | 24 | 64 |
2023 December | 41 | 26 | 67 |
2023 November | 56 | 55 | 111 |
2023 October | 45 | 30 | 75 |
2023 September | 38 | 30 | 68 |
2023 August | 39 | 30 | 69 |
2023 July | 43 | 35 | 78 |
2023 June | 59 | 22 | 81 |
2023 May | 80 | 37 | 117 |
2023 April | 51 | 21 | 72 |
2023 March | 76 | 31 | 107 |
2023 February | 44 | 22 | 66 |
2023 January | 48 | 13 | 61 |
2022 December | 64 | 37 | 101 |
2022 November | 79 | 52 | 131 |
2022 October | 56 | 52 | 108 |
2022 September | 62 | 31 | 93 |
2022 August | 67 | 48 | 115 |
2022 July | 53 | 62 | 115 |
2022 June | 54 | 30 | 84 |
2022 May | 87 | 41 | 128 |
2022 April | 83 | 57 | 140 |
2022 March | 52 | 56 | 108 |
2022 February | 59 | 59 | 118 |
2022 January | 58 | 57 | 115 |
2021 December | 50 | 43 | 93 |
2021 November | 48 | 43 | 91 |
2021 October | 72 | 51 | 123 |
2021 September | 82 | 44 | 126 |
2021 August | 79 | 41 | 120 |
2021 July | 62 | 34 | 96 |
2021 June | 46 | 18 | 64 |
2021 May | 66 | 29 | 95 |
2021 April | 185 | 39 | 224 |
2021 March | 115 | 33 | 148 |
2021 February | 138 | 24 | 162 |
2021 January | 80 | 14 | 94 |
2020 December | 66 | 6 | 72 |
2020 November | 82 | 19 | 101 |
2020 October | 54 | 22 | 76 |
2020 September | 47 | 17 | 64 |
2020 August | 52 | 9 | 61 |
2020 July | 48 | 5 | 53 |
2020 June | 44 | 14 | 58 |
2020 May | 77 | 15 | 92 |
2020 April | 43 | 18 | 61 |
2020 March | 49 | 11 | 60 |
2020 February | 65 | 25 | 90 |
2020 January | 92 | 29 | 121 |
2019 December | 70 | 17 | 87 |
2019 November | 60 | 26 | 86 |
2019 October | 42 | 15 | 57 |
2019 September | 53 | 14 | 67 |
2019 August | 36 | 9 | 45 |
2019 July | 44 | 21 | 65 |
2019 June | 29 | 10 | 39 |
2019 May | 33 | 7 | 40 |
2019 April | 67 | 44 | 111 |
2019 March | 36 | 15 | 51 |
2019 February | 12 | 9 | 21 |
2019 January | 31 | 20 | 51 |
2018 December | 52 | 26 | 78 |
2018 November | 64 | 16 | 80 |
2018 October | 72 | 11 | 83 |
2018 September | 53 | 8 | 61 |
2018 August | 36 | 14 | 50 |
2018 July | 32 | 5 | 37 |
2018 June | 25 | 9 | 34 |
2018 May | 33 | 15 | 48 |
2018 April | 24 | 6 | 30 |
2018 March | 28 | 7 | 35 |
2018 February | 24 | 7 | 31 |
2018 January | 35 | 6 | 41 |
2017 December | 40 | 11 | 51 |
2017 November | 25 | 5 | 30 |
2017 October | 24 | 9 | 33 |
2017 September | 37 | 10 | 47 |
2017 August | 31 | 16 | 47 |
2017 July | 37 | 11 | 48 |
2017 June | 34 | 9 | 43 |
2017 May | 33 | 6 | 39 |
2017 April | 36 | 14 | 50 |
2017 March | 17 | 14 | 31 |
2017 February | 29 | 20 | 49 |
2017 January | 20 | 16 | 36 |
2016 December | 68 | 12 | 80 |
2016 November | 86 | 8 | 94 |
2016 October | 109 | 5 | 114 |
2016 September | 129 | 5 | 134 |
2016 August | 163 | 8 | 171 |
2016 July | 136 | 9 | 145 |
2016 June | 97 | 0 | 97 |
2016 May | 105 | 0 | 105 |
2016 April | 83 | 0 | 83 |
2016 March | 63 | 0 | 63 |
2016 February | 93 | 0 | 93 |
2016 January | 73 | 0 | 73 |
2015 December | 78 | 0 | 78 |
2015 November | 90 | 0 | 90 |
2015 October | 78 | 0 | 78 |
2015 September | 59 | 0 | 59 |
2015 August | 66 | 0 | 66 |
2015 July | 48 | 0 | 48 |
2015 June | 39 | 0 | 39 |
2015 May | 59 | 0 | 59 |
2015 April | 6 | 0 | 6 |